Bijesh Kumar Biswal (Bijesh K Biswal)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Molecular biology reports

Biotechnology journal

Journal of cellular biochemistry

Medicinal research reviews

National Institute of Technology Rourkela

Indian Institute of Technology Madras (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institute of Technology Rourkela Jul 03 2015

India

Assistant Professor :: Life Science

Education History

Indian Institute of Technology Madras

India

PHD :: Biotechnology

Publications

Rajeev Kumar Sahoo, Surya Kant Tripathi, Stuti Biswal, Munmun Panda, Santosh S Mathapati, Bijesh Kumar Biswal
Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics. Biotechnology journal 19 (2) (2024)
Rajeev Kumar Sahoo, Surya Kant Tripathi, Stuti Biswal, Munmun Panda, Santosh S Mathapati, Bijesh Kumar Biswal
Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics. Biotechnology journal 19 (2) (2024)
Munmun Panda, Stuti Biswal, Bijesh Kumar Biswal
Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β-catenin axis. Molecular biology reports 51 (1) (2024)
Munmun Panda, Stuti Biswal, Bijesh Kumar Biswal
Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β-catenin axis. Molecular biology reports 51 (1) (2024)
Shikshya Swarupa Panda, Bijesh Kumar Biswal
The phytochemical plumbagin: mechanism behind its "pleiotropic" nature and potential as an anticancer treatment. Archives of toxicology (2024)
Munmun Panda, Surya Kant Tripathi, Gokhan Zengin, Bijesh Kumar Biswal
Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers. Cell biology and toxicology (2022)
Munmun Panda, Bijesh Kumar Biswal
Evodiamine inhibits stemness and metastasis by altering the SOX9-β-catenin axis in non-small-cell lung cancer. Journal of cellular biochemistry 123 (9) (2022)
Subrata Kumar Padhan, Janmejaya Bag, Munmun Panda, Bijesh Kumar Biswal, Harekrushna Sahoo, Monalisa Mishra, Satya Narayan Sahu
Synthesis of First Coumarin Fluorescent Dye for Actin Visualization. Bioconjugate chemistry 33 (11) (2022)
Munmun Panda, Surya Kant Tripathi, Bijesh Kumar Biswal
Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation. Molecular biology reports 47 (6) (2020)
Surya Kant Tripathi, Kannan R R Rengasamy, Bijesh Kumar Biswal
Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction. Archives of pharmacal research 43 (2) (2020)
Surya Kant Tripathi, Kamal Pandey, Kannan R R Rengasamy, Bijesh Kumar Biswal
Recent updates on the resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors and resistance reversion strategies in lung cancer. Medicinal research reviews 40 (6) (2020)
Munmun Panda, Bijesh Kumar Biswal
Cell signaling and cancer: a mechanistic insight into drug resistance. Molecular biology reports 46 (5) (2019)

Bijesh Kumar Biswal.css-eqlu8i{font-size:small;padding-left:4px;} (Bijesh K Biswal)

Publication Activity (10 Years)

Top Topics

Top Venues

Bijesh Kumar Biswal (Bijesh K Biswal)